The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Independent validation of progression-free survival rate at 9 and 18 weeks (PFSR-18, PFSR-9) as predictor for overall survival (OS) in patients with malignant pleural mesothelioma (MPM): EORTC 08052 study.
Baktiar Hasan
No relevant relationships to disclose
Athanasios G. Pallis
No relevant relationships to disclose
Rabab Mohamed Gaafar
No relevant relationships to disclose
Laurent Greillier
No relevant relationships to disclose
Jan P. Van Meerbeeck
No relevant relationships to disclose
Mary O'Brien
No relevant relationships to disclose